36198.1 IP-LS

Résumé

Development of novel diagnostic test to provide personalized antibiotic therapy regimen for tuberculosis patients

Textes supplémentaires

Abstract

The global drive to eradicate tuberculosis with the help of new drug regimens is faced with a lack of rapid and precise diagnostics to direct therapy. In this project we develop the first diagnostic tests enabling optimal use of old and new antibiotics, directly from patient samples within 24 hours.

Participants

Peter Keller

Kontaktperson

peter.keller@ifik.unibe.ch

Universität Bern Peter Keller Friedbühlstrasse 51 3010 Bern BE CH

Sebastian Dümcke

Wirtschaftspartner

duemcke@clemedi.com

Clemedi AG CHE-387.097.262 Sebastian Dümcke Wagistrasse 12 8952 Schlieren ZH CH

Détails du projet

Office de recherche: INNOSUISSE
Statut du projet: Abgeschlossen
Type de projet: Forschungsprojekt
Date de début: 2020-09-30
Date de fin: 2023-02-28
Coûts totaux approuvés: CHF 713193.80
Section: 60 Life Sciences
Domaine politique NABS: Industrielle Produktivität und Technologie

Disciplines de recherche

B725 Diagnostics 100.0%